- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Dopamine Receptor D3 (DRD3) Antibody |
| Catalog No. | NSMA-0180 |
| Description | Targeted at the D3 receptor, this antibody is used to study the limbic system's dopaminergic pathways and is a key target for addiction and schizophrenia research. |
| Host Species | Rabbit |
| Isotype | IgG |
| Specificity | Human DRD3 |
| Immunogen | Recombinant human DRD3 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purity | Affinity Purified |
| Concentration | 0.9 mg/mL |
| Buffer | PBS, pH 7.4 |
| Preservative | 0.05% Sodium Azide |
| Stability | 18 months |
| Storage | -20°C |
| Applications | WB, IHC, IF |
| Reactivity | Human, Mouse, Rat |
| Molecular Weight | 44 kDa |
| Sensitivity | High |
| Cross-Reactivity | No cross with DRD2 |
| Background Staining | Low |
| Clonality | Polyclonal |
| Usage Level | Research/IVD Grade |
| Shipping Condition | Blue Ice |
| Solubility | Aqueous |
| Biological Activity | Receptor signaling active |
| Target System | Limbic System |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagenoTech. All rights reserved.
